HedgePath Pharmaceuticals, Inc. 5
5 · HedgePath Pharmaceuticals, Inc. · Filed Feb 6, 2015
Insider Transaction Report
Form 5
Cross Stefan
Director
Transactions
- Award
Restricted Stock Units
2014-07-18+300,000→ 300,000 total→ Common Stock (300,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a right to receive one share of the issuer's common stock.
- [F2]The RSUs were issued to the reporting person on July 18, 2014, pursuant to a grant under the issuer's 2014 Equity Incentive Plan. The RSUs will vest on the earlier to occur of (i) September 3, 2016 and (ii) the receipt of written notice of acceptance for the filing of an NDA by the issuer for the its patented formulation of the drug itraconazole, known as SUBATM-Itraconazole, in a particular dose formulation for the treatment of human patients with cancer via oral administration.